Geoff Bell is the CEO of MicroBioGen, a world-leading industrial yeast biotechnology company. Over the past 15 years, Geoff has facilitated MicroBioGen’s transformation from a small, pure research group into an international commercial success for bioethanol production. Highly qualified, with a Bachelor of Science, a Bachelor of Economics and a Master of Applied Finance from the University of Sydney and Macquarie University, Geoff has also gained extensive commercial experience. He was a Senior Analyst at two global investment banks, Prudential-Bache Securities and BNP Paribas Equities, and he became the Head of three BNP departments: Global Mining, Australian Research, and Company Research for the Asia Pacific Region. Geoff was the top-rated analyst in his field for over a decade and he won several industry accolades for his outstanding insight and analytical work. He also serves as the Australian leader for IEA Task 42, a program considering biorefining in a circular economy.